Valeant

September 9, 2019 - A proposed partial settlement has been reached with PricewaterhouseCoopers LLP on behalf of certain investors in the common shares and notes of Valeant Pharmaceuticals International Inc. A hearing to determine if the settlement will be approved will take place on November 11, 2019. For more details or to opt out of the proposed settlement, please see the below documents or contact Jon Sloan at 1-866-881-2292 ext. 299 or [email protected].

Settlement Long Form Notice and Opt Out Form (English)

Settlement Long Form Notice and Opt Out Form (French)

PwC Settlement Agreement

Plan of Allocation